We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Sally Beauty Holdings
SBH
$1.58B
| $5.47M | ﹤0.01% |
434,395
+98,658
| +29% | +$1.37M |
|
1827
Myriad Genetics
MYGN
$312M
| $5.46M | ﹤0.01% |
286,380
-5,746
| -2% | -$132K |
|
1828
Urban Edge Properties
UE
$2.73B
| $5.45M | ﹤0.01% |
408,763
-12,193
| -3% | -$190K |
|
|
CTEV
1829
Claritev Corp
CTEV
$556M
| $5.45M | ﹤0.01% |
47,638
+491
| +1% | +$81.2K |
|
1830
Perdoceo Education
PRDO
$2.12B
| $5.44M | ﹤0.01% |
528,397
+271,060
| +105% | +$3.24M |
|
|
VRAY
1831
DELISTED
ViewRay, Inc.
VRAY
| $5.43M | ﹤0.01% |
1,491,431
-391,931
| -21% | -$1.32M |
|
1832
Mercury Insurance
MCY
$6.07B
| $5.42M | ﹤0.01% |
190,642
+87,071
| +84% | +$3.16M |
|
|
SASR
1833
DELISTED
Sandy Spring Bancorp Inc
SASR
| $5.42M | ﹤0.01% |
153,605
-4,329
| -3% | -$171K |
|
1834
Provident Financial Services
PFS
$3.19B
| $5.41M | ﹤0.01% |
277,196
+8,155
| +3% | +$190K |
|
1835
Nu Skin
NUS
$267M
| $5.38M | ﹤0.01% |
161,182
-2,857
| -2% | -$119K |
|
1836
Global Net Lease
GNL
$1.95B
| $5.38M | ﹤0.01% |
504,996
-52,016
| -9% | -$724K |
|
|
FTCH
1837
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $5.38M | ﹤0.01% |
723,535
+24,239
| +3% | +$215K |
|
1838
Shake Shack
SHAK
$2.87B
| $5.37M | ﹤0.01% |
119,405
-1,348
| -1% | -$64.7K |
|
1839
AngioDynamics
ANGO
$649M
| $5.36M | ﹤0.01% |
262,104
-4,670
| -2% | -$103K |
|
|
TPH
1840
DELISTED
Tri Pointe Homes
TPH
| $5.36M | ﹤0.01% |
354,787
-11,481
| -3% | -$203K |
|
1841
Columbia Sportswear
COLM
$2.94B
| $5.35M | ﹤0.01% |
79,536
-1,845
| -2% | -$135K |
|
|
HEES
1842
DELISTED
H&E Equipment Services
HEES
| $5.35M | ﹤0.01% |
188,828
+96,974
| +106% | +$3.05M |
|
1843
Lakeland Financial Corp
LKFN
$1.53B
| $5.35M | ﹤0.01% |
73,422
-1,162
| -2% | -$86.6K |
|
1844
TTEC Holdings
TTEC
$124M
| $5.34M | ﹤0.01% |
120,602
+2,097
| +2% | +$125K |
|
1845
Accel Entertainment
ACEL
$987M
| $5.33M | ﹤0.01% |
682,930
+228,585
| +50% | +$2.32M |
|
1846
Portillo's
PTLO
$321M
| $5.33M | ﹤0.01% |
270,506
+207,696
| +331% | +$4.57M |
|
1847
Greif
GEF
$5.04B
| $5.32M | ﹤0.01% |
89,345
-2,194
| -2% | -$146K |
|
|
CLR
1848
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.32M | ﹤0.01% |
79,571
+2,397
| +3% | +$162K |
|
1849
Energizer
ENR
$1.55B
| $5.31M | ﹤0.01% |
211,228
-4,165
| -2% | -$121K |
|
1850
AZZ Inc
AZZ
$4.54B
| $5.3M | ﹤0.01% |
145,225
+3,893
| +3% | +$162K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.